Panbela Therapeutics, Inc.
PBLADelisted Apr 25, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001029125
Panbela Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 19, 2024; 11 institutions reported holding it in 13F filings for Q4 2023, worth $115.8K in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Panbela Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 15 | 17 | +2 |
| Shares | 693.6K | 1.12M | +429.1K (+61.9%) |
| Value | $2.74M | $3.12M | +$383.0K (+14.0%) |
New holders (7)
Institutions that held Panbela Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Murchinson Ltd. | 150,000 | $425.0K | 0.15% |
| CVI Holdings, LLC | 41,667 | $118.0K | 0.01% |
| NewGen Asset Management Ltd | 40,000 | $113.0K | 0.05% |
| Buckingham Strategic Wealth, LLC | 24,927 | $71.0K | 0.00% |
| BlackRock Inc. | 24,020 | $68.0K | 0.00% |
| Warberg Asset Management LLC | 11,567 | $33.0K | 0.01% |
| UBS Group AG | 286 | $1.00K | 0.00% |
Sold out (5)
Institutions that held Panbela Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Squarepoint Ops LLC | 15,538 | $61.0K |
| Valeo Financial Advisors, LLC | 2,500 | $10.0K |
| Tower Research Capital LLC (TRC) | 864 | $3.00K |
| Advisor Group Holdings, Inc. | 350 | $1.00K |
| Bank of America Corp | 11 | $0 |